This is a Validated Antibody Database (VAD) review about rhesus mac.. GZMB, based on 54 published articles (read how Labome selects the articles), using GZMB antibody in all methods. It is aimed to help Labome visitors find the most suited GZMB antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
mouse monoclonal (GB11)
  • other; human; 1:25; loading ...; fig 2f
Invitrogen GZMB antibody (ThermoFisher Scientific, MA1-80734) was used in other on human samples at 1:25 (fig 2f). elife (2019) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 2f
Invitrogen GZMB antibody (Thermo Fisher, GB11) was used in flow cytometry on human samples (fig 2f). Front Immunol (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen GZMB antibody (eBioscience, GB11) was used in flow cytometry on human samples (fig 3b). J Exp Med (2018) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3a
In order to evaluate the role of IL-32alpha in NK cell inhibition, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3d
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, Invitrogen GZMB antibody (eBiosciences, GB11) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3a
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 3a). Immunity (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6m
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 6m). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 3c
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, Invitrogen GZMB antibody (eBioscience, GB11) was used in flow cytometry on human samples (fig 3c). Clin Exp Immunol (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, Invitrogen GZMB antibody (LifeTechnologies/Invitrogen, GB11) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 1
In order to characterize mediation of anti-viral cytotoxicity by type 1 interferon licenses naive CD8 T cells, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 1). Virology (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . Nature (2016) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; 1:50; fig 5
In order to elucidate restriction of west nile virus infection and pathogenesis in a region-specific and cell-type manner by the interferon-stimulated gene Ifi2712a, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples at 1:50 (fig 5). J Virol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 2f
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, Invitrogen GZMB antibody (Life technologies, GB11) was used in flow cytometry on mouse samples (fig 2f). Retrovirology (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; loading ...; fig 10a
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 10a). J Exp Med (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; loading ...; fig 1
In order to investigate the role of granzyme B in T regulatory cell resistance, Invitrogen GZMB antibody (eBioscience, GB11) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to examine the role of GPR18 in intestinal intraepithelial lymphocytes, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
In order to investigate the effect of SGI-110 on cancer testis antigen gene-regulated expression, Invitrogen GZMB antibody (Invitrogen, clone GB11) was used in flow cytometry on human samples (fig 5). Leuk Res (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 7
In order to determine virus-induced immune suppression of CD8 T cell responses caused by out-of-sequence signal 3, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 7). PLoS Pathog (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to investigate incomplete immunity against intracellular pathogens in neonates, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to assess T regulatory type 1 cell therapy in patients with high-risk/advanced stage hematologic malignancies, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
Invitrogen GZMB antibody (Invitrogen, clone GB11) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to characterize the Treg populations the Friend retrovirus mouse model, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . Virol Sin (2014) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (GB11)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to identify ADP-ribosylation factor-like 8b as a factor required for natural killer cell-mediated cytotoxicity, Invitrogen GZMB antibody (Caltag, GB11) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Mol Biol Cell (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to report that FoxO1 regulates effector-to-memory transition and functional maturation of memory CD4 and CD8 T cells, Invitrogen GZMB antibody (Invitrogen, clone GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 4
In order to investigate the suppressive activity of Tregs on effector CD4(+) T cells in retroviral infection, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 4). J Virol (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to study the pulmonary immune response to Francisella tularensis, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 2). Microbes Infect (2013) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to examine how NK cells integrate signals induced by stress and antibody-coated cells, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3
In order to study the role of IL-15 and IL-7 on CD8 T cells during infection with Toxoplasma gondii, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 3). Microbes Infect (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
In order to study HIV-specific CD8 T cells, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 5). Blood (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; rhesus macaque; loading ...; fig 4a
In order to optimize a DNA vaccine to boost cellular immune responses induced by Ad5 prime, Invitrogen GZMB antibody (Invitrogen, GRB11) was used in flow cytometry on rhesus macaque samples (fig 4a). Vaccine (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; African green monkey; fig 6
In order to elucidate immune mechanisms that facilitate viral clearance and contribute to persistent lung inflammation following SARS-CoV infection, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on African green monkey samples (fig 6). J Virol (2012) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on human samples . J Exp Med (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; rhesus macaque; fig 2
In order to characterize different macaque NK cell subpopulations, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on rhesus macaque samples (fig 2). Immunology (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3
In order to elucidate the role of TRAIL in the pulmonary CD8 T cell response to influenza A virus, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 3). J Immunol (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 4
In order to suggest that PD-1 expression during acute infection is not a marker of T cell exhaustion, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 4). J Immunol (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 3
In order to study the contribution of the cellular immune response in maintaining nonpathogenic SIV infection in sooty mangabeys, Invitrogen GZMB antibody (Invitrogen, clone GB11-PETxRed) was used in flow cytometry on human samples (fig 3). J Immunol (2011) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to investigate how bystander CD8 cells are impacted during viral infection, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2010) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6
In order to use a transgenic mouse model of spontaneous astrocytoma to study immune infiltrate, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 6). Cancer Res (2010) ncbi
mouse monoclonal (GB11)
  • immunocytochemistry; human
In order to investigate the effect of perforin on specific endocytosis process, Invitrogen GZMB antibody (Caltag Laboratories, GB11) was used in immunocytochemistry on human samples . Blood (2010) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 1
In order to explore how naive CD4 cells differentiate into class II restricted killers, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 1). Cell Immunol (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 5b
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen GZMB antibody (Caltag Laboratories, GB11) was used in flow cytometry on mouse samples (fig 5b). J Immunol (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human
In order to elucidate the role of interleukin-15 in human natural killer cell development, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on human samples . J Exp Med (2009) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5
In order to determine the importance of TRAIL to influenza-specific CD8(+) T cell immunity and control of the infection, Invitrogen GZMB antibody (Invitrogen, GB11) was used in flow cytometry on human samples (fig 5). J Immunol (2008) ncbi
mouse monoclonal (GB11)
  • flow cytometry; human; fig 5C
  • flow cytometry; mouse; fig 3B
In order to determine if clonal expansion and acquisition of effector functions driven by antigen presenting cells is reshaped during the effector phase to adapt to the effector site microenvironment in murine brain tumor models, Invitrogen GZMB antibody (Invitrogen/ Life Technologies, GB11) was used in flow cytometry on human samples (fig 5C) and in flow cytometry on mouse samples (fig 3B). J Immunol (2007) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 7
In order to elucidate CTLA-4 regulation of cytotoxic T lymphocytes in a transgenic model of CD8+ T-cell-mediated myocarditis, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 7). Circ Res (2007) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to report that NKT cells produce IL-21 and that IL-21 regulates NKT function, Invitrogen GZMB antibody (Caltag Laboratories, GB11) was used in flow cytometry on mouse samples (fig 2). J Immunol (2007) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse
In order to study CD8+ T cell responses during herpesvirus infection, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples . J Virol (2006) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 6
In order to study the effects of prolonged antigen exposure, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 6). J Immunol (2006) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 3
In order to examine the role of T-bet in Valpha14i natural killer T cell function, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 3). Blood (2006) ncbi
mouse monoclonal (GB11)
  • flow cytometry; mouse; fig 2
In order to evaluate the therapeutic potential of different tumor-reactive CD8+ T cell memory subsets in vivo, Invitrogen GZMB antibody (Caltag, GB11) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2005) ncbi
Bio-Rad
mouse monoclonal (GB11)
  • flow cytometry; human
In order to study NK function in solid tumors, Bio-Rad GZMB antibody (AbD Serotec, GB11) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
Articles Reviewed
  1. Ramaglia V, Sheikh Mohamed S, Legg K, Park C, Rojas O, Zandee S, et al. Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry. elife. 2019;8: pubmed publisher
  2. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed publisher
  3. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  4. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed publisher
  5. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  6. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  7. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  8. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  9. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  10. Urban S, Berg L, Welsh R. Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity. Virology. 2016;493:52-9 pubmed publisher
  11. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  12. Lucas T, Richner J, Diamond M. The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner. J Virol. 2015;90:2600-15 pubmed publisher
  13. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  14. Herz J, Johnson K, McGavern D. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015;212:1153-69 pubmed publisher
  15. Bhela S, Kempsell C, Manohar M, Dominguez Villar M, Griffin R, Bhatt P, et al. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J Immunol. 2015;194:2180-9 pubmed publisher
  16. Wang X, Sumida H, Cyster J. GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment. J Exp Med. 2014;211:2351-9 pubmed publisher
  17. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Karbach J, et al. Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts. Leuk Res. 2014;38:1332-41 pubmed publisher
  18. Urban S, Welsh R. Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses. PLoS Pathog. 2014;10:e1004357 pubmed publisher
  19. Boding L, Hansen A, Meroni G, Johansen B, Braunstein T, Bonefeld C, et al. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells. Eur J Immunol. 2014;44:3109-18 pubmed publisher
  20. Smith N, Wissink E, Wang J, Pinello J, Davenport M, Grimson A, et al. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol. 2014;193:177-84 pubmed publisher
  21. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  22. Bacchetta R, Lucarelli B, Sartirana C, Gregori S, Lupo Stanghellini M, Miqueu P, et al. Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells. Front Immunol. 2014;5:16 pubmed publisher
  23. Poonia B, Pauza C. Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. PLoS ONE. 2014;9:e88884 pubmed publisher
  24. Joedicke J, Dietze K, Zelinskyy G, Dittmer U. The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virol Sin. 2014;29:48-60 pubmed publisher
  25. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed publisher
  26. Tuli A, Thiery J, James A, Michelet X, Sharma M, Garg S, et al. Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity. Mol Biol Cell. 2013;24:3721-35 pubmed publisher
  27. Tejera M, Kim E, Sullivan J, Plisch E, Suresh M. FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory. J Immunol. 2013;191:187-99 pubmed publisher
  28. Manzke N, Akhmetzyanova I, Hasenkrug K, Trilling M, Zelinskyy G, Dittmer U. CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells. J Virol. 2013;87:6306-13 pubmed publisher
  29. Schmitt D, O Dee D, Brown M, Horzempa J, Russo B, Morel P, et al. Role of NK cells in host defense against pulmonary type A Francisella tularensis infection. Microbes Infect. 2013;15:201-11 pubmed publisher
  30. Deguine J, Breart B, Lemaitre F, Bousso P. Cutting edge: tumor-targeting antibodies enhance NKG2D-mediated NK cell cytotoxicity by stabilizing NK cell-tumor cell interactions. J Immunol. 2012;189:5493-7 pubmed publisher
  31. Bhadra R, Khan I. IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite. Microbes Infect. 2012;14:1160-8 pubmed publisher
  32. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  33. Ribeiro Dos Santos P, Turnbull E, Monteiro M, Legrand A, Conrod K, Baalwa J, et al. Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors. Blood. 2012;119:4928-38 pubmed publisher
  34. Hutnick N, Myles D, Hirao L, Scott V, Ferraro B, Khan A, et al. An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge. Vaccine. 2012;30:3202-8 pubmed publisher
  35. CLAY C, Donart N, Fomukong N, Knight J, Lei W, Price L, et al. Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge. J Virol. 2012;86:4234-44 pubmed publisher
  36. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher
  37. Vargas Inchaustegui D, Demberg T, Robert Guroff M. A CD8?(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology. 2011;134:326-40 pubmed publisher
  38. Brincks E, Gurung P, Langlois R, Hemann E, Legge K, Griffith T. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. J Immunol. 2011;187:4581-8 pubmed publisher
  39. Zelinskyy G, Myers L, Dietze K, Gibbert K, Roggendorf M, Liu J, et al. Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol. 2011;187:3730-7 pubmed publisher
  40. Meythaler M, Wang Z, Martinot A, Pryputniewicz S, Kasheta M, McClure H, et al. Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection. J Immunol. 2011;186:5151-61 pubmed publisher
  41. Marshall H, Prince A, Berg L, Welsh R. IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J Immunol. 2010;185:1419-28 pubmed publisher
  42. Tran Thang N, Derouazi M, Philippin G, Arcidiaco S, Di Berardino Besson W, Masson F, et al. Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. Cancer Res. 2010;70:4829-39 pubmed publisher
  43. Thiery J, Keefe D, Saffarian S, Martinvalet D, Walch M, Boucrot E, et al. Perforin activates clathrin- and dynamin-dependent endocytosis, which is required for plasma membrane repair and delivery of granzyme B for granzyme-mediated apoptosis. Blood. 2010;115:1582-93 pubmed publisher
  44. Brown D, Kamperschroer C, Dilzer A, Roberts D, Swain S. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Cell Immunol. 2009;257:69-79 pubmed publisher
  45. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  46. Huntington N, Legrand N, Alves N, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206:25-34 pubmed publisher
  47. Brincks E, Katewa A, Kucaba T, Griffith T, Legge K. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol. 2008;181:4918-25 pubmed
  48. Masson F, Calzascia T, Di Berardino Besson W, De Tribolet N, Dietrich P, Walker P. Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells. J Immunol. 2007;179:845-53 pubmed
  49. Love V, Grabie N, Duramad P, Stavrakis G, Sharpe A, Lichtman A. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circ Res. 2007;101:248-57 pubmed
  50. Coquet J, Kyparissoudis K, Pellicci D, Besra G, Berzins S, Smyth M, et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol. 2007;178:2827-34 pubmed
  51. Obar J, Fuse S, Leung E, Bellfy S, Usherwood E. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J Virol. 2006;80:8303-15 pubmed
  52. Yang T, Millar J, Groves T, Grinshtein N, Parsons R, Takenaka S, et al. The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J Immunol. 2006;176:200-10 pubmed
  53. Matsuda J, Zhang Q, Ndonye R, Richardson S, Howell A, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood. 2006;107:2797-805 pubmed
  54. Klebanoff C, Gattinoni L, Torabi Parizi P, Kerstann K, Cardones A, Finkelstein S, et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A. 2005;102:9571-6 pubmed